STIM Form 144: Proposed sale of 2,925,554 shares via Morgan Stanley

Rhea-AI Filing Summary

Neuronetics, Inc. (STIM) filed a Form 144 reporting a proposed sale of 2,925,554 common shares, with an aggregate market value of $10,883,060.88. The filing lists Morgan Stanley Smith Barney LLC as the broker and indicates the shares are to be sold on NASDAQ with an approximate sale date of 08/08/2025.

The notice shows the shares were acquired on 12/10/2024 in connection with a Merger/Acquisition from the issuer and were paid for in cash. The filer reports nothing to report for securities sold in the past three months and includes the standard representation that they are not aware of any undisclosed material adverse information about the issuer.

Positive

• Form 144 filed to disclose proposed sale, satisfying Rule 144 reporting requirements
• Shares were acquired in a Merger/Acquisition and paid in cash on 12/10/2024
• No securities sold by the filer in the past three months ("Nothing to Report")

Negative

• Proposed sale of 2,925,554 shares (~4.43% of 66,124,820 outstanding)
• Filer CIK and certain submission contact fields appear blank in the provided content

Insights

Securities Analyst

TL;DR: Routine Rule 144 notice for ~2.93M shares; size is notable but below a common 5% materiality threshold.

The filing documents a proposed sale of 2,925,554 shares valued at $10.9 million, representing approximately 4.43% of the issuer's 66,124,820 outstanding shares. From a trading-liquidity perspective, a sale of this magnitude can add supply, but it is below the 5% threshold often used to flag materially dilutive or market-moving insider dispositions. The shares were acquired in a merger and paid in cash on 12/10/2024, and no securities sales were reported in the prior three months. Overall, this appears to be a compliant, standard Rule 144 notice rather than an exceptional corporate development.

Corporate Governance Expert

TL;DR: Disclosure meets Rule 144 elements; lack of some filer contact identifiers in provided content is a documentation gap.

The form contains the necessary transaction details: class of security, broker, number of shares, aggregate market value, acquisition date and nature (merger/acquisition), and planned sale date. These items satisfy key Rule 144 notice elements. However, the provided content shows missing filer identifiers and contact fields, which could complicate verification if not present in the official submission. The seller's representation that no undisclosed material adverse information exists is included, aligning with the form's attestation requirements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2925554	10883060.88	66124820	08/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/10/2024	Merger/Acquisition	Issuer			2925554	12/10/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Neuronetics (STIM) report in this Form 144?

Neuronetics reported a proposed sale of 2,925,554 common shares via Form 144, with a listed aggregate market value of $10,883,060.88.

Who is the broker handling the proposed sale for STIM?

Morgan Stanley Smith Barney LLC is named as the broker, with an address at Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004 in the filing.

When were the shares acquired and how were they paid for?

The shares were acquired on 12/10/2024 in a Merger/Acquisition transaction from the issuer and were paid for in cash on that date.

When is the approximate date of sale and on which exchange will STIM shares be sold?

The filing lists an approximate sale date of 08/08/2025 and names NASDAQ as the securities exchange.

Did the filer report any securities sold in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.